Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Recruiting N/A Interventional Study
Stable Coronary Artery Disease Acute Coronary Syndromes Critical Limb Ischemia Intermittent Claudication
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
60 (estimated)
Sponsor
Maria Cecilia Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages. This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with chronic coronary artery disease; * Patients with no-ST elevation acute coronary syndrome; * Patients with chronic claudication (Rutherford II-III) * Patients with critical limb ischemia (Rutherford IV-V). Exclusion Criteria: * Severe renal dysfunction * Severe …
Contacts

Roberto Nerla, MD, PhD

+390545217032

robertonerla83@gmail.com

CONTACT